inhibits monocyte hydrogen peroxide chemiluminescence measurements MS patients controls Monocytes active sites multiple sclerosis MS demyelination local tissue injury inflammatory response part production toxic oxygen metabolites Corticosteroids MS exacerbations inadequate knowledge mechanism effects new class steroid derivatives glucocorticoid mineralocorticoid effects production hydrogen peroxide chemiluminescence stimulated monocytes stable MS patients age- sex-matched controls measurements chemiluminescence groups results production toxic oxygen metabolites monocytes inflammatory potential agents effective safe treatment MS exacerbations 